OOCSL
About this security
OCSL is a 6.48% preferred stock issued by Oaktree Specialty Lending Corp.
Issuer page — all Oaktree Specialty Lending Corp securities & profile →
Key Stats structural terms pending prospectus match consistency checks passed — not source-verified
⚠ Liquidation preference not yet confirmed from the prospectus ("par pending"), so premium/discount and yield-to-call are withheld rather than computed from an assumed value. Price, yield, and dividends are exact from the market feed.
Quote
| OCSL (preferred) | |
|---|---|
| Last | $11.86 |
| Change | — |
| Open | $11.81 |
| High / Low | $12.00 / $11.75 |
| Prev Close | — |
| Volume | 684,547 |
| 52-Week High / Low | $14.77 / $10.63 |
52-week range based on available history. Shares outstanding / market cap require a fundamentals feed (not in current data plan).
Price
Dividend History
| Ex-Date | Amount / Share |
|---|---|
| 2026-06-15 | $0.340000 |
| 2026-03-16 | $0.400000 |
| 2025-12-15 | $0.400000 |
| 2025-09-15 | $0.400000 |
| 2025-06-16 | $0.420000 |
| 2025-03-17 | $0.470000 |
| 2024-12-16 | $0.550000 |
| 2024-09-16 | $0.550000 |
| 2024-06-14 | $0.550000 |
| 2024-03-14 | $0.550000 |
| 2023-12-14 | $0.620000 |
| 2023-09-14 | $0.550000 |
Performance — $10K Calculator
Dividends reinvested (DRIP) at the close on each ex-date. Full performance page →
News — Oaktree Specialty Lending Corp
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS — globenewswire.com · Jun 16, 2026
- Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities — globenewswire.com · Jun 15, 2026
- OCS Investors Have Opportunity to Join Oculis Holding AG Fraud Investigation with the Schall Law Firm — prnewswire.com · Jun 11, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS — prnewswire.com · Jun 11, 2026
- Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026 — globenewswire.com · Jun 11, 2026
- Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026 — globenewswire.com · Jun 11, 2026
- Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities — globenewswire.com · Jun 10, 2026
- Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities — globenewswire.com · Jun 09, 2026
Issuer news via Tiingo, tagged to OCS.